Skip to main content

Table 1 Clinical descriptions of the patients with DRONJ

From: Denosumab-associated jaw bone necrosis in cancer patients: retrospective descriptive case series study

 

Patient 1

Patient 2

Patient 3

Patient 4

Sex

Male

Male

Female

Male

Age

65

75

79

82

Primary cancer

Prostate

Prostate

Breast

Prostate

Concomitant treatment

Docetaxel

Corticosteroids

Docetaxel Enzalutamide

Corticosteroids

Trastuzumab

Docetaxel

Corticosteroids

ONJ-related underlying diseases

-

Diabetes

Diabetes Rheumatoid arthritis

-

ONJ site

Mandible posterior

Mandible posterior

Mandible anterior

Maxilla anterior

Cause of onset

Tooth extraction

Tooth extraction

Spontaneous onset

Tooth extraction, denture

Number of injections at the time of DRONJ diagnosis

13

10

12

1

A cycle of DMB injection (month)

1

1

1.5

-

Duration of the DMB treatment before onset (month)

11

6

19

2

Interval between extraction and last DMB injection (month)

1

1

-

2

Duration of drug holiday before the ONJ surgery (month)

6

1

4.5

-

Healing period after ONJ surgery (month)

2

2

1st surgery: 5

2nd surgery: 5

a

Actinomyces finding

Y

Y

Y

-

DRONJ status at the end of follow up

Stabilization

Stabilization

Stabilization

Unknown/death

  1. aNo follow-up